Thrombotic thrombocytopenic purpura
Bérangère S. Joly(Inserm), Agnès Veyradier(Inserm)
Cited by 685
Related Papers
Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
|Journal of Thrombosis and Haemostasis|2014|139
Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the <scp>F</scp>rench thrombotic microangiopathies reference center
|American Journal of Hematology|2015|47
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre
|American Journal of Hematology|2017|42
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
|EClinicalMedicine|2025|41
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes
|Nephrology Dialysis Transplantation|2024|8